¿Es necesario resecar siempre las recidivas de los tumores vesicales superficiales en el momento del diagnostico?: comunicación preliminar

Cáceres, P. Martínez; Arroyo, Jacqueline; Toniolo, G

doi:10.1016/s0210-4806(05)73298-8

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

¿Es necesario resecar siempre las recidivas de los tumores vesicales superficiales en el momento del diagnostico?: comunicación preliminar

Abstract: Due to the low risk of progression, we believe that immediate eradication is not always necessary, thus reducing the adverse impact of repeat resections.

Cited by 5 publications

References 9 publications

Active Surveillance for Low-Risk Non-Muscle Invasive Bladder Cancer

Active Surveillance for Low-Risk Non-Muscle Invasive Bladder Cancer

Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project

Drug strategies for bladder cancer in the elderly: is there promise for the future?

Contact Info

Product

Resources

About